Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351)

Journal of Nuclear Medicine

Volumn 38, Issue 5, 1997, Pages 675-682

  Chengazi, Vaseem U ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

monoclonal antibody; prostate cancer; prostate specific antigen; technetium 99m

Indexed keywords

CYT 351; MONOCLONAL ANTIBODY TC 99M; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER SCINTISCANNING; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; HUMAN; IMAGE QUALITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

ANTIBODIES, MONOCLONAL; BONE NEOPLASMS; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOIMMUNODETECTION; SOFT TISSUE NEOPLASMS; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030912576     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Scardino PT. Problem of prostate cancer. J Urol 1994;152:1677-1678.
2. Gervasi LA, Mata J, Easley JD, et al. Prognostic significance of lymph nodal métastases in prostate cancer. J Urol 1989; 142:332-336.
3. Paulson DF. Impact of radical prostatectomy in the management of clinically localised disease. J Urol 1994; 152:1826-1830.
4. Golimbu M, Morales P, Al-Askari, et al. CAT scanning in staging of prostate cancer. Urology 1981;3:305-308.
5. Weinerman PM, Arger PH, Pollack HM. CT evaluation of bladder and prostate neoplasms. Urol Radial 1982;4:105-114.
6. Bez/i M, Kressel HY, Allen KS, et al. Prostatic carcinoma: staging with MR imaging at 1.5T. Radiology 1988;l69:339-346.
7. Hrieak H. Noninvasive imaging for staging of prostate cancer: magnetic resonance imaging, computed tomography and ultrasound. NCI Monogr 1988:7:31 35.
8. Chisholm GD, Short MD, Ghanadian R, et al. Radiozinc uptake and scintiscanning in prostatic disease. J Nucl Med 1974; 15:739 742.
9. Bergen B. Coffey DS, Scott WW. Concepts and limitations of radiolabelled antiandrogens, oestrogens, or androgens as isotopic scanning agents for the prostate. Investing Urol 1975; 13:10 16.
10. Babaian RJ, Lamki LM. Radioimmunoscintigraphy of prostate cancer. Semin Nucl Med 1989:4:309 321.
11. Horoszewicz JS, Kawinski E, Murphy GP. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 1987:7:927-936.
12. Murphy GP. Lucy Wortham James basic research award: markers of prostatic carcinoma. Arch Surg 1991; 126:1404-1407.
13. Gulfo JV. Clinical utility of monoclonal antibodies in prostate cancer. In: Dawson NA, Vogelzang NJ, eds. Prostate cancer. New York: Wiley-Liss; 1994:77-94.
14. Mather SJ, Ellison D. Reduction mediated technetium-99m-labeling of monoclonal antibodies. J Nucl Med 1990;5:692-697.
15. 99mTc [Abstract]. Nucl Med Commun 1995;16:241.
16. Buraggi GL, Turrin A, Cascinelli N, et al. Immunoscintigraphy with antimelanoma monoclonal antibodies. In: Cox P, ed. Monographs in nuclear medicine, volume 1. Reading, U.K.: Gordon and Breach Science Publishers; 1984:215-253.
17. Britton KE, Granowska M. Radioimmunoscintigraphy in tumor identification. Cancer Surv 1987;6:247-267.
18. Babaian RJ, Sayer J, Podoloff DA, et al. Radioimmunoscintigraphy of pelvic lymph nodes with ' "in-labeled monoclonal antibody CYT-356. J Urol 1994; 152:1952-1955.
19. Sanford E, Grzonka R, Heal A, et al. Prostate cancer imaging with a new monoclonal antibody: a preliminary report. Ann Surg Oncol 1994;5:400-404.
20. Kotz D. Monoclonal antibody scan holds promise for prostate cancer imaging. J Nucl Afe/4:1996;llN-15N.
21. O'Connor MK, Kelly BJ. Evaluation of techniques for the elimination of "hot" bladder artefacts in SPECT of the pelvis. J Nucl Med 1990;11:1872-1875.
22. Chengazi VU, Nimmon CC, Britton KE. Forward projection analysis and image surgery: an approach to quantitative tomography. International Atomic Energy Agency and World Health Organization Symposium "Tomography in Nuclear Medicine, Present Status and Future Prospects. 1996:31-44.
23. Mettlin C, Murphy GP, Lee F, et al. Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project. J Urol 1994;152:1737 -1740.